Previous close | 241.88 |
Open | 243.27 |
Bid | 243.94 x 800 |
Ask | 246.22 x 900 |
Day's range | 242.69 - 246.59 |
52-week range | 229.86 - 287.32 |
Volume | |
Avg. volume | 1,472,524 |
Market cap | 71.223B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 56.54 |
EPS (TTM) | 4.36 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | 3.80 (1.54%) |
Ex-dividend date | 07 Mar 2024 |
1y target est | 278.54 |
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey conducted by The Harris Poll that reveals that many patients receive too many needlesticks in hospital procedures and amplifies misconceptions and lack of awareness from Americans on the risks of common medical procedures.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2024 list of America's Most Innovative Companies.
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.